Evidence map›Paper›PMID 41254789›Full record

ReviewBiotechnology for biofuels and bioproducts2025

From the bench to the reactor: engineered filamentous fungi for biochemical and biomaterial production.

Venkataramanan Subramanian, Meaghan J Adler, Marcus Benyamin, Randi M Pullen, Matthew D Servinsky, Mark T Kozlowski, Stephen R Decker

Abstract readReview
In one paragraph

Review in Biotechnology for biofuels and bioproducts, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Venkataramanan SubramanianNational Renewable Energy Laboratory, 15013 Denver West Parkway, Golden, CO, 80401, USA.
Meaghan J AdlerCombat Capabilities Development Command, Army Research Laboratory, 2800 Powder Mill Rd, Adelphi, MD, 20783, USA.
Marcus BenyaminCombat Capabilities Development Command, Army Research Laboratory, 2800 Powder Mill Rd, Adelphi, MD, 20783, USA.
Randi M PullenCombat Capabilities Development Command, Army Research Laboratory, 2800 Powder Mill Rd, Adelphi, MD, 20783, USA.
Matthew D ServinskyCombat Capabilities Development Command, Army Research Laboratory, 2800 Powder Mill Rd, Adelphi, MD, 20783, USA.
Mark T KozlowskiCombat Capabilities Development Command, Army Research Laboratory, 2800 Powder Mill Rd, Adelphi, MD, 20783, USA. mark.t.kozlowski4.civ@army.mil.
Stephen R DeckerNational Renewable Energy Laboratory, 15013 Denver West Parkway, Golden, CO, 80401, USA.

Funding

U.S. Department of Energy Bioenergy Technologies Office DE-AC36-08GO28308
6 · The paper itself

Abstract

Filamentous fungi can convert a wide variety of naturally occurring chemical compounds, including organic biomass and waste streams, into a range of products. They have long been used for industrial organic acid production and food preparation. In this review, we will discuss production of products such as organic acids, lipids, small molecules, enzymes, materials, and foods, and highlight advances in metabolic and protein engineering, including CRISPR-Cas9-mediated strain improvements. We discuss to what extent these products are already being made on a commercial scale, as well as what is still required to make certain promising concepts industrially and commercially relevant. Despite significant progress, the systematic application of synthetic biology to filamentous fungi remains in its infancy, with many opportunities for discovery and innovation as new strains and genetic tools are developed. The integration of fungal biotechnology into circular and bio-based economies promises to address critical challenges in waste management, resource sustainability, and the development of new materials for terrestrial and extraterrestrial applications, but requires further developments in genetic engineering and process design.

Identifiers

PMID41254789
PMCPMC12625039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.